Assoicated Medical Conditions for Type 1 Diabetes

The following is based on bacteria published studies. These are report on the averages of a group of patients; they do not apply to all patients and are not necessary predictive.

For some medical conditions there are hundreds of bacteria shifts reported, for others only a few. The Percentage is based on the least number. If there are matches 8 matches for a condition that has 10 known bacteria shifts, against a condition that has 50 bacteria shifts. It will be 8/10 or 80% and not 8/50= 16%. The count of possible bacteria is shown for reference.

Associations

Limited to conditions with 5 or more bacteria

Name Percent Est Matches Bacteria in From Bacteris in To
Acne 26.3 % 5 19 52
ADHD 21.3 % 10 47 52
Allergic Rhinitis (Hay Fever) 13.9 % 5 36 52
Allergies 16 % 8 50 52
Alzheimer's disease 32 % 16 50 52
Amyotrophic lateral sclerosis (ALS) Motor Neuron 23.3 % 10 43 52
Ankylosing spondylitis 42.3 % 22 520 52
Asthma 14.8 % 4 27 52
Atherosclerosis 32.7 % 17 524 52
Autism 32.7 % 17 110 52
Barrett esophagus cancer 12.5 % 2 16 52
Bipolar Disorder 33.3 % 11 33 52
Brain Trauma 31.8 % 7 22 52
Carcinoma 13.7 % 7 51 52
Celiac Disease 19.2 % 10 67 52
Cerebral Palsy 29.4 % 5 17 52
Chronic Fatigue Syndrome 13.5 % 7 55 52
Chronic Kidney Disease 25.7 % 9 35 52
Chronic Urticaria (Hives) 21.7 % 5 23 52
Colorectal Cancer 23.1 % 12 296 52
Coronary artery disease 12.5 % 2 16 52
COVID-19 11.1 % 4 36 52
Crohn's Disease 36.5 % 19 141 52
cystic fibrosis 14.3 % 1 7 52
Depression 23.1 % 12 81 52
Epilepsy 24 % 6 25 52
Fibromyalgia 16.2 % 6 37 52
Functional constipation / chronic idiopathic constipation 24.4 % 10 41 52
gallstone disease (gsd) 33.3 % 5 15 52
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 16.7 % 4 24 52
Gout 14.3 % 3 21 52
Graves' disease 37.5 % 3 8 52
Hashimoto's thyroiditis 21.4 % 3 14 52
High Blood Pressure 14.9 % 7 47 52
hypercholesterolemia (High Cholesterol) 22.2 % 2 9 52
Hyperlipidemia (High Blood Fats) 20 % 5 25 52
hypertension (High Blood Pressure 66.7 % 4 6 52
IgA nephropathy (IgAN) 20.7 % 6 29 52
Inflammatory Bowel Disease 26.9 % 14 66 52
Insomnia 70 % 7 10 52
Irritable Bowel Syndrome 23.1 % 12 62 52
Liver Cirrhosis 53.8 % 28 678 52
ME/CFS with IBS 10.5 % 2 19 52
Metabolic Syndrome 14.3 % 1 7 52
Mood Disorders 16.7 % 1 6 52
Multiple Sclerosis 30.8 % 16 100 52
Multiple system atrophy (MSA) 14.3 % 3 21 52
neuropsychiatric disorders (PANDAS, PANS) 20 % 3 15 52
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 17.3 % 9 76 52
Obesity 19.2 % 10 104 52
Obesity 13.5 % 7 55 52
Osteoporosis 18.2 % 4 22 52
Parkinson's Disease 21.2 % 11 90 52
Psoriasis 19.6 % 9 46 52
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 34.6 % 18 134 52
Rosacea 40.9 % 9 22 52
Schizophrenia 28.8 % 15 93 52
Sjögren syndrome 22 % 9 41 52
Stress / posttraumatic stress disorder 11.5 % 6 56 52
Systemic Lupus Erythematosus 28.8 % 15 66 52
Type 2 Diabetes 67.3 % 35 267 52
Ulcerative colitis 30.8 % 16 108 52

(Legacy User)

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.